Navigation Links
GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Date:12/11/2007

ppropriate patient, it is an important treatment option for health-care professionals managing the chronic and life threatening disease of diabetes. Across multiple sources of data, there is no consistent or systematic evidence that rosiglitazone increases the risk of myocardial ischemic events or death in comparison to other anti-diabetic agents.

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit GlaxoSmithKline on the World Wide Web at http://www.gsk.com.

Important Safety Information for Avandia(R) (rosiglitazone maleate)

Avandia, along with diet and exercise, helps improve blood sugar control in patients with type 2 diabetes.

Avandia can cause or worsen heart failure. If you have severe heart failure (very poor pumping ability of the heart), you cannot be started on Avandia. Avandia is also not recommended if you have heart failure with symptoms (such as shortness of breath or swelling) even if these symptoms are not severe.

Avandia may increase your risk of other heart problems that occur when there is reduced blood flow to the heart, such as chest pain (angina) or heart attack (myocardial infarction). This risk appeared higher in patients taking medicines called nitrates or insulin. Taking Avandia with insulin or with nitrates is not recommended.

If you have chest pain or a feeling of chest pressure, you should seek immediate medical attention, regardless of what diabetes medicines you are taking.
If you take Avandia, tell your doctor right away if you:

-- Have swollen legs or ankles, a rapid increase in weight or difficulty

breathing, or unusual tiredness

-- Experience changes in vision

-- Become pregnant

Re
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
7. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
8. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
9. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
10. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... PA (PRWEB) February 26, 2015 ... 9 -12, at the Ernest N. Morial Convention ... exhibitors (count as of February 19, 2015) displaying ... in industrial, academic, and government labs. The Exposition ... as, but not limited to, analytical chemistry; drug ...
(Date:2/26/2015)... 26, 2015 Innovation is more ... from unexpected parts of the world and transforming ... agriculture to manufacturing to health care, disruption is ... realities and socio-political trends shake the foundations of ... ingredient for CEOs to survive the next wave ...
(Date:2/26/2015)... According to a new market report published by ... (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and ... and Forecast, 2013 – 2019,”the global agricultural biotechnology market ... is expected to reach USD 28,694.1 million by 2019, ... 2019. , Demand for food production has increased ...
(Date:2/26/2015)... IL (PRWEB) February 26, 2015 Regis ... for the development of oncology drug substances. , Regis ... up of their new Potent Compound Suite (PCS) for ... a 36,000 square foot, cGMP facility in Morton Grove, ... cGMP manufacturing of potent compounds up to about one ...
Breaking Biology Technology:Pittcon 2015 Announces Exposition Highlights 2One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Regis Extends cGMP Services to Oncology Market 2
... Directors, EXTON, Pa., Nov. 5 Isolagen(TM), Inc. ... Meeting of,Stockholders, held today in Exton, Pennsylvania. Stockholders ... new Director.,Dr. Selzer has been a partner with the ... Selzer has been executive director,of the Hallowell-West Medical Center, ...
... Nov. 5 deCODE genetics,(Nasdaq: DCGN ) today ... 30, 2007. A conference call to discuss the,quarter,s results ... November 6, at 8:00am Eastern Standard Time/1pm GMT,(details below). ... 2007 was $24.2 million,compared to $23.6 million for the ...
... Will be Core Application for ... Wellness Programs, WASHINGTON, Nov. 5 Netsmart ... services for health and,human services organizations, today announced ... health software and provide related services to the,Detroit ...
Cached Biology Technology:Isolagen, Inc. Reports Results of Shareholders Annual Meeting 2Isolagen, Inc. Reports Results of Shareholders Annual Meeting 3deCODE genetics Announces Third Quarter 2007 Financial Results 2deCODE genetics Announces Third Quarter 2007 Financial Results 3deCODE genetics Announces Third Quarter 2007 Financial Results 4deCODE genetics Announces Third Quarter 2007 Financial Results 5deCODE genetics Announces Third Quarter 2007 Financial Results 6deCODE genetics Announces Third Quarter 2007 Financial Results 7deCODE genetics Announces Third Quarter 2007 Financial Results 8deCODE genetics Announces Third Quarter 2007 Financial Results 9Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software 2
(Date:1/22/2015)... 15, 2015  BellBrook Labs, a leader in high ... launch of a TR-FRET (time resolved Forster resonance ... Assay, a high throughput screening assay for glycosyltransferases ... allow for sensitive detection of hundreds of human ...
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
(Date:1/22/2015)... N.C. , Jan. 22, 2015 Infinisource has launched ... of the G2 model. The G2 sets a higher standard ... iSolved human capital management solution. With plug-and-play installation, touch screen ... time clock provides a robust time collection solution for the ...
Breaking Biology News(10 mins):BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Infinisource's NXG series sets new time clock standard 2
... Micro-organisms occurring naturally in coastal mudflats have an essential ... down petrochemical residues. Research by Dr Efe Aganbi and ... Society for General Microbiology,s meeting at Harrogate today (Monday ... degradation of the chemicals depending on whether or not ...
... 12-year-old Dutch boy bedridden for three years because ... join his friends on the soccer field thanks to ... , The investigators, led by Bjrn Knollmann, M.D., Ph.D., ... the clinically available drug flecainide prevents potentially lethal arrhythmias ...
... in Nature , researchers at Brandeis University and the ... time shed light on a crucial step in the complex ... in the human cell and frequently at which point genetic ... they were able to crystallize a very large complex of ...
Cached Biology News:Microbes in mud flats clean up oil spill chemicals 2Targeted drug therapy prevents exercise-induced arrhythmias 2Targeted drug therapy prevents exercise-induced arrhythmias 3A splice of life 2
... Radiant Red fluorescent RNA stain is ... denaturing (formaldehyde or glyoxal) agarose gels and ... excitation with a 302 nm transilluminator, the ... be photographed on Polaroid film or with ...
... costs. More efficient interfacing with mass ... volumes. Industry demands for benefits like ... chromatography for routine applications. Standard HPLC ... the need to operate with smaller ...
From the company that first brought you the chromatin immunoprecipitation (ChIP) kit, a new and improved kit, EZ-ChIP, is now available to make your experiments easier, quicker, and most importantly,...
... for the PDS-1000 He biolistic system enables 7-10 ... standard system. It fits into the shocking chamber ... the helium shock wave over 7 microcarriers. By ... over this larger area, the system maximizes the ...
Biology Products: